AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06393114 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Unfermented oat-based product
Description: Participants will incorporate a novel unfermented product into their habitual diet for three weeks. Dietary adjustments and other guidance are consistent with those described during the fermented product intervention.
Study NCT06557850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG22515
Description: Solution for infusion
Study NCT05916092 — intervention group
Intervention type: DEVICE
Intervention: TransLoc 3D
Description: TransLoc 3D SI Joint Fusion System
Study NCT05214313 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: The standardised music therapy protocol of 45 minutes will include at each session :~* 10 min of musical listening in a soothing environment (relaxation chair and reduced and coloured lighting) in sensory isolation (with headphones) and aimed at relaxation as a preamble to the active phase of the protocol~* Active phase: (25 min)~* 5 min of receptive music therapy linked to a given emotion, different at each session (joy, sadness, anger and fear) aimed at emotional management (feeling and distancing),~* 20 minutes of active music therapy with instrumental and vocal improvisation that solicits the body physiologically,~* 10 minutes of musical listening in sensory isolation for a state of rest.~The entire protocol is carried out with the permanent perception of heartbeats set to a physiological frequency of 50 to 100 BPM.
Study NCT06232668 — intervention group
Intervention type: PROCEDURE
Intervention: Chorionic biopsy and peripheral blood collection in cases group
Description: Chorionic villi will be collected from women who have a recommendation for aneuploidy testing, and the remaining fragment will be used for this study and peripheral blood collection in cases group. Clinical data will be compiled.
Study NCT06232668 — intervention group
Intervention type: PROCEDURE
Intervention: Chorionic biopsy and peripheral blood collection in control group
Description: Chorionic villi will be collected from women who have a recommendation for aneuploidy testing, and the remaining fragment will be used for this study and peripheral blood collection in control group. Clinical data will be compiled.
Study NCT03921944 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: CT scan of the shoulders
Description: studies of both operative and nonoperative shoulders
Study NCT05020262 — intervention group
Intervention type: OTHER
Intervention: CT Image reconstruction
Description: Retrospectively collects CT Images and reconstruct using PI/PC and Idose4/Cardiac Images to assessment the performance of the two new software functions of Incisive CT. No direct intervention to patients. And ICF is exempted by EC.
Study NCT04802096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: inspiratory muscle training
Description: Intensity of inspiratory muscle training will be set at 30% of maximal inspiratory pressure. Subjects in intervention experimental group will perform 15 breaths per set, 6 sets per day on daily basis. The intervention will be last for 8 weeks.
Study NCT04802096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pulmonary rehabilitation
Description: Pulmonary rehabilitation consists of aerobic exercise training, strength training, and education related to airway clearance and drug utilization. All of subjects will receive 8-week pulmonary rehabilitation.
Study NCT04802096 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: pulmonary rehabilitation
Description: Pulmonary rehabilitation consists of aerobic exercise training, strength training, and education related to airway clearance and drug utilization. All of subjects will receive 8-week pulmonary rehabilitation.
Study NCT06112223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Patients will receive oral gabapentin 600 mg 1 hour before the surgery.
Study NCT06112223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: Patients will receive oral tramadol 100 mg 1 hour before the surgery.
Study NCT06062459 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Control Exercise
Description: Motor control exercises focusing on the activation and control of deep spinal muscles
Study NCT06062459 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance Training
Description: Balance training exercises on to enhance proprioception and stability
Study NCT06062459 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: Participants received hot pack and stretching exercise
Study NCT06062459 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Participants received hot pack and stretching exercise
Study NCT06562634 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: erector spinea plane block
Description: an echogenic 22-G block needle is inserted in-plane to the ultrasound beam in a cranial-to-caudal direction until contact was made with the L4 transverse process. Correct location of the needle tip in the fascial plane deep to erector spinae muscle is confirmed by injecting 0.5-1 ml saline and seeing the fluid lifting the erector spinae muscle off the transverse process while not distending the muscle. A total of 20ml bupivicaine 0.25%, and 20 ml xylocaine 1% will be injected into the ESP on the affected side.
Study NCT06562634 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine Sulfate
Description: intravenous morphine will be given in a dose of 0.1-0.2mg/kg to maintain intraoperative analgesia.
Study NCT04736446 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: I-gel® supraglottic device
Description: Use of an i-gel® supraglottic device to deliver ventilations
Study NCT04736446 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Face mask ventilation
Description: Use of a face mask to deliver ventilations
Study NCT04929288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: Participants will complete three experimental sessions. In each session, participants will provide detailed reports of their alcohol consumption over the past five days, and they will provide a blood sample for hormone assays. They will perform tasks during fMRI to assess each of the neurofunctional addiction domains: inhibitory control, negative emotionality, and cue reactivity. Following the fMRI scan, subjects will self-administer intravenous alcohol to provide a controlled assessment of pharmacologically-driven alcohol consumption.
Study NCT06301607 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Oro-esophageal Tube Feeding
Description: The group is given enteral nutritional support with Intermittent Oro-esophageal Tube according to the following procedure: Before each feeding, inside and outside of the tube was cleaned with water. During feeding, the patient should maintain a semi-reclining or sitting position with mouth opened, and the tube was inserted slowly and smoothly into the upper part of the esophagus by medical staffs while the appropriate depth of intubation was checked with the calibration markings on the tube wall. The distance from the incisors to the head part of the tube should be between 22-25 cm. However, the specific depth should be evaluated based on patients' feedback and adjusted accordingly. After insertion, the tail part of the tube should be put into a container full of water and the absence of continuous bubbles indicated a successful intubation. Then, the feeding was to be conducted three times per day with 50 ml per minute and 400-600ml for each feeding.
Study NCT06301607 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nasogastric Tube
Description: The group is given enteral nutritional support with Nasogastric Tube Feeding according to the relevant guidelines. Within 4 hours after admission, the placement of the feeding tube was conducted by professional medical staffs and after intubation, the tube was secured to the patient\&#39;s cheek with medical tape. The feeding was conducted once every 3-4 hours, with 200-300ml each time. The total feeding volume was determined based on daily requirements. The feeding content was formulated by the nutritionists based on the patient\&#39;s condition and relevant guidelines to reach the energy demand as 20-25 kcal/kg/day and protein supplementation of 1.2-2.0 g/kg/day for both two groups. For patients with limited tube feeding compliance, we made appropriate adjustments to ensure that they were not at risk of severe malnutrition as much as possible.
Study NCT06301607 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: comprehensive rehabilitation therapy
Description: Including： Basic treatment, including corresponding control of risk factors and education on healthy lifestyles.~Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training.~Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
Study NCT06301607 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: comprehensive rehabilitation therapy
Description: Including： Basic treatment, including corresponding control of risk factors and education on healthy lifestyles.~Swallowing training, including lemon ice stimulation, mendelson maneuver, empty swallowing training, and pronunciation training.~Pulmonary function training, including standing training, cough training, and diaphragm muscle training.
Study NCT05744310 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Long term mechanical ventilation support
Description: Patients that choose life prolonging treatment with long term mechanical ventilation support
Study NCT05744310 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: No long term mechanical ventilation support
Description: Patients that decline life prolonging treatment with long term mechanical ventilation support
Study NCT06569173 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LaiKai anti-reflux ureteral stent
Description: Ureteral stents are serving to support the ureter and facilitate urine drainage with an anti-reflux valve.
Study NCT06569173 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: LaiKai Ureteral Stent
Description: Ureteral stents are serving to support the ureter and facilitate urine drainage.
Study NCT05326828 — intervention group
Intervention type: DEVICE
Intervention: CONFIRM Rx implantable cardiac rhythm monitor (Abbott)
Description: Implantation of CONFIRM Rx ICM
Study NCT05326828 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Systematic etiologic work-up for underlying causes of MINOCA
Description: Intracoronary optical coherence tomography, cardiac magnetic resonance imaging, transesophageal echocardiography, vasospasm testing, thrombophilia screening, Holter ECG (only non-ICM group)
Study NCT06559865 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathing exercises
Description: as per group description
Study NCT05062980 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: quaratusugene ozeplasmid
Description: Quaratusugene ozeplasmid is an experimental non-viral therapy utilizing the TUSC2 gene, designed to target cancer cells by interrupting cell signaling pathways that allow cancer cells to grow, re-establishing pathways that promote cancer cell death and modulating the immune system response against cancer cells.
Study NCT05062980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: Pembrolizumab is a programmed death receptor-1 (PD-1) blocking antibody indicated for treatment of patients with metastatic NSCLC.
Study NCT05062980 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: docetaxel
Description: Docetaxel is a microtubule inhibitor indicated for locally advanced or metastatic NSCLC after platinum-based chemotherapy failure.
Study NCT05062980 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ramucirumab
Description: Ramucirumab is a human vascular endothelial growth factor receptor 2 (VEGFR2) antagonist indicated in combination with docetaxel for treatment of NSCLC with disease progression after platinum-based chemotherapy.
Study NCT05062980 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Investigator's Treatment of Choice
Description: Treatment will be administered during 21-day treatment cycles. The investigator's treatment must not include investigational drugs or therapies.
Study NCT04846036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sonlicromanol
Description: Oral administration of sonlicromanol twice daily
Study NCT04846036 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral administration of matching placebo twice daily
Study NCT06292780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linvoseltamab
Description: anti-B-cell maturation antigen x anti-Cluster of differentiation 3 bispecific antibody
Study NCT05766332 — intervention group
Intervention type: OTHER
Intervention: Clinical Evaluation
Description: Undergo clinical evaluation
Study NCT05766332 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical records reviewed
Study NCT05206565 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neurotization - Autologous Reconstruction with DIEP/TRAM
Description: * Transverse Rectus Abdominis Muscle/Deep Inferior Epigastric Artery Flap Harvest - Prior to elevation of flaps in the suprafascial plane from using loupe magnification to identify medial and lateral row of perforators bilaterally, sensory nerves T10-12 are identified and dissected into the muscle bilaterally to prepare for nerve coaptation, nerves are divided at the level of the fascia where they are pure sensory nerves.~* Chest Intercostal Nerve Harvest - During standard of care chest vessel dissection, intercostal nerves T3-4 are identified. After completion of vein coupling it will be determined whether neurotization can be performed or if autograft. Primary nerve coaptation will be performed if there is adequate length for direct end to end apposition.~* Coaptation of nerve or nerve graft endings will be performed using 9-0 nylon suture in an interrupted fashion.
Study NCT06081920 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IBI363
Description: IBI363 monotherapy
Study NCT06315296 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Dietary Intervention
Description: Follow a time-restricted diet
Study NCT06337890 — intervention group
Intervention type: PROCEDURE
Intervention: Zero contrast FEVAR
Description: Use of automated CO2 angiographies with Fusion Imaging for zero contrast FEVAR
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Message-Based Navigation Intervention
Description: Receive interactive positive reinforcement messages
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention
Description: Use txt4fasting platform
Study NCT06315296 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary Counseling and Surveillance
Description: Receive counseling calls
Study NCT06315296 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Radiosurgery
Description: Undergo SRS
Study NCT06315296 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06315296 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo brain MRI
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurocognitive Assessment
Description: Ancillary studies
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Internet-Based Intervention
Description: Use txt4fasting platform
Study NCT06315296 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Stereotactic Radiosurgery
Description: Undergo SRS
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Text Message-Based Navigation Intervention
Description: Receive text messages about healthy eating habits and food suggestions
Study NCT06315296 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06315296 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo brain MRI
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurocognitive Assessment
Description: Ancillary studies
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06315296 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interview
Description: Ancillary studies
Study NCT04816019 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCov-19
Description: A single dose of ChAdOx1 nCov-19 delivered intranasally (IN)
Study NCT04804995 — intervention group
Intervention type: OTHER
Intervention: There is no intervention.
Description: No intervention.
Study NCT04777357 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cariprazine
Description: Oral Capsule
Study NCT04777357 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Capsule
Study NCT06079177 — intervention group
Intervention type: DEVICE
Intervention: Ultrasound
Description: LUS using B-lines Caval-Aorta index using ultrasound
Study NCT05004805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylene Blue
Description: MB administered topically as a 0.02% solution nasal spray in COVID-19 patients requiring hospitalization.
Study NCT05004805 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline nasal spray
Description: Saline administered topically as nasal spray in COVID-19 patients requiring hospitalization.
Study NCT04980820 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No mask
Description: The participant is asked to wear no mask for 10 minutes.
Study NCT04980820 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Filtering face mask 2 (FFP2)
Description: The participant is asked to wear a FFP2 mask for 1 hour during work.
Study NCT04980820 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Filtering face mask 3 (FFP3)
Description: The participant is asked to wear a FFP3 mask for 1 hour during work.
Study NCT05473572 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fluency shaping exercises
Description: Training for prolonged speech, easy onset, light contact and abdominal breathing moving from the level of single words till using short sentences describing pictures
Study NCT05061277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recifercept
Description: A lyophilized powder for solution for injection
Study NCT05156892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SUBA-itraconazole
Description: 150 mg BD
Study NCT05932056 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Miles de Manos (Thousands of Hands)
Description: Miles de Manos (Thousands of Hands) is a school-based group intervention that incorporates elements of evidence-based behavior management interventions in parent, teacher, and parent-teacher joint sessions.
Study NCT05156892 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: Dose Escalation:~Cohort 1: 20 mg OD Cohort 2: 40 mg OD Cohort 3: 60 mg OD~Dose-Expansion: Recommended dose from dose-escalation phase of study
Study NCT05794984 — intervention group
Intervention type: OTHER
Intervention: Focus group discussions and survey questionnaire
Description: Questions regarding internet and social media usage, as well as telemedicine concept and knowledge. Assessment of the feasibility, acceptability and accessibility of social media and telemedicine as methods to obtain healthcare. Perceptions for high-quality healthcare access, confidentiality, privacy, and security, will also be explored.
Study NCT05679531 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intervention
Description: After filling out the patient information form, the patients who met the research criteria were chewed gum for an average of 15 minutes.
Study NCT04492605 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: consume 1 capsule per day for 2 months
Study NCT04492605 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: TCI378 Probiotics
Description: consume 1 capsule per day for 2 months
Study NCT04492605 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: TCI507 Probiotics
Description: consume 1 capsule per day for 2 months
Study NCT05528939 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EndeavorRx
Description: EndeavorRx is a digital intervention delivered through an action video game that is indicated to improve attention function. EndeavorRx users first complete two discrete tasks: 1) a perceptual discrimination/attention task in which users respond to target stimuli and ignore distractor stimuli (e.g., tapping the screen quickly only when red aliens appear) and 2) a sensorimotor navigation task in which users tilt their device to steer a hovercraft down a river while targeting or avoiding certain objects. Users are subsequently presented with a multitask training session where they complete the perceptual discrimination/attention task and the sensorimotor navigation task simultaneously. Algorithms adapt the program in both real-time and between sessions to automatically adjust the difficulty level.